EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol

Tamana Alozai iD, Yee Lai Lam, Michiel A Schreve, André Aea de Smet, Anco C Vahl, Liesbeth C Terlouw-Punt, Çağdaş Ünlü, Cees Ha Wittens

Phlebology: The Journal of Venous Disease · 2023

DOI: 10.1177/02683555231189414 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Phlebology: The Journal of Venous Disease, 2023. Verfasst von Tamana Alozai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Northwest Clinics, Alkmaar, the Netherlands. Hauptthemen laut MEDLINE: Endovascular Procedures, Varicose Veins, Venous Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Vascular Insights.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to compare patient-reported outcomes after technical success (TS) and technical failure (TF) in treating great saphenous vein incompetence (GSV) with ClariVein.

Methods

A subanalysis of a previous trial was conducted on symptomatic GSV incompetence patients who received ClariVein treatment with 2% or 3% polidocanol (POL) and were followed for 6 months. Blinding was implemented for observers and patients, and data from both POL groups were combined. TS was defined as at least 85% occlusion of the treated vein, while TF indicated failure to meet TS criteria. Secondary outcomes included Venous Clinical Severity Score (VCSS), Aberdeen Varicose Vein Questionnaire (AVVQ), and Short-Form 36 Health Survey Questionnaire (SF-36).

Results

Among the 364 patients included, the TS rate was 64.5%. Comparison of VCSS, AVVQ, and SF-36 scores between TS and TF groups did not yield significant differences.

Conclusion

This study indicates no significant variation in VCSS, AVVQ, and SF-36 scores between patients experiencing TS and TF following ClariVein treatment for GSV insufficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endovascular ProceduresVaricose VeinsVenous InsufficiencyHumansPolidocanolSaphenous VeinTreatment OutcomePatient Reported Outcome MeasuresQuality of LifePolyethylene Glycols

Stichwörter der Autor:innen

ClariVeinMOCAMechanochemical ablationendovenous ablationgreat saphenous veinpatient-reported outcome measures (PROMs)quality of lifevaricose veins

Substanzen

Polidocanoldodecylnonaoxyethylene glycol monoetherPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Surgery, Northwest Clinics, Alkmaar, the Netherlands.
  • Department of Surgery, Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Department of Dermatology, Zaans Medisch Centrum, Zaandam, the Netherlands.
  • Department of Surgery, Red Cross Hospital, Beverwijk, the Netherlands.
  • Department of Vascular Surgery, Maasstad Hospital, Rotterdam, the Netherlands.
  • Department of Vascular Surgery, OLVG, Amsterdam, the Netherlands.

ORCID-Profile: Tamana Alozai

Förderung

  • Vascular Insights

Zitieren

APA

Alozai, T., Lam, Y. L., Schreve, M. A., de Smet, A. A., Vahl, A. C., Terlouw-Punt, L. C., Ünlü, Ç., & Wittens, C. H. (2023). A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol. Phlebology: The Journal of Venous Disease. https://doi.org/10.1177/02683555231189414

Vancouver

Alozai T, Lam YL, Schreve MA, de Smet AA, Vahl AC, Terlouw-Punt LC, et al. A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol. Phlebology: The Journal of Venous Disease. 2023. doi:10.1177/02683555231189414

BibTeX
@article{Alozai2023,
  author = {Alozai, Tamana and Lam, Yee Lai and Schreve, Michiel A and de Smet, André Aea and Vahl, Anco C and Terlouw-Punt, Liesbeth C and Ünlü, Çağdaş and Wittens, Cees Ha},
  title = {A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol},
  journal = {Phlebology: The Journal of Venous Disease},
  year = {2023},
  doi = {10.1177/02683555231189414}
}
Kostenlos starten →